THYMANAX

This brand name is authorized in Austria, Estonia, Croatia, Ireland, Lithuania, Poland

Active ingredients

The drug THYMANAX contains one active pharmaceutical ingredient (API):

1 Agomelatine UNII 137R1N49AD - AGOMELATINE

Agomelatine is a melatonergic agonist (MT1 and MT2 receptors) and 5-HT2C antagonist. In humans, agomelatine has positive phase shifting properties; it induces a phase advance of sleep, body temperature decline and melatonin onset. Read about Agomelatine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
THYMANAX Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AX22	Agomelatine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX22

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1412233, 1412244, 1412255, 1412266, 1412277, 1412288, 1412299, 1412301
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1037126, 1037127, 1037129, 1037130, 1037131, 1037132
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100315427